Cargando…

Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis

Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441

Detalles Bibliográficos
Autores principales:	Rivière, Elodie, Sellam, Jérémie, Pascaud, Juliette, Ravaud, Philippe, Gottenberg, Jacques-Eric, Mariette, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994091/ https://www.ncbi.nlm.nih.gov/pubmed/29884223 http://dx.doi.org/10.1186/s13075-018-1628-6

Ejemplares similares

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
por: Sellam, Jérémie, et al.
Publicado: (2016)

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
por: Sellam, Jérémie, et al.
Publicado: (2017)

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
por: Virone, Alexandre, et al.
Publicado: (2019)

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
por: Sellam, Jérémie, et al.
Publicado: (2009)

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2019)

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2009)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
por: Nourisson, Cynthia, et al.
Publicado: (2017)

Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis
por: Li, Chun, et al.
Publicado: (2014)

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
por: Alsaleh, Ghada, et al.
Publicado: (2010)

Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome
por: Dupré, Anastasia, et al.
Publicado: (2021)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
por: Blaess, Julien, et al.
Publicado: (2020)

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
por: Ittah, Marc, et al.
Publicado: (2006)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis
por: Paoletti, Audrey, et al.
Publicado: (2022)

Increased IL-33 in Synovial Fluid and Paired Serum Is Associated with Disease Activity and Autoantibodies in Rheumatoid Arthritis
por: Tang, Sumei, et al.
Publicado: (2013)

The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis
por: García-Arellano, Samuel, et al.
Publicado: (2021)

Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort
por: Seror, Raphaèle, et al.
Publicado: (2016)

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
por: Kamradt, Thomas, et al.
Publicado: (2013)

IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis
por: Chen, Si, et al.
Publicado: (2017)

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies
por: Miceli-Richard, Corinne, et al.
Publicado: (2009)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies
por: Bitoun, Samuel, et al.
Publicado: (2023)

Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’ – authors’ reply
por: Sellam, Jérémie, et al.
Publicado: (2014)

Lymphoma complicating rheumatoid arthritis: results from a French case–control study
por: Kedra, Joanna, et al.
Publicado: (2021)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022)

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study
por: Courvoisier, D.S., et al.
Publicado: (2016)

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2006)

CTLA-4 polymorphism and primary Sjögren's syndrome: authors' response
por: Miceli-Richard, Corinne, et al.
Publicado: (2007)

Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
por: Iwaszko, Milena, et al.
Publicado: (2021)

Jin-Wu-Jian-Gu Formulation Attenuates Rheumatoid Arthritis by Inhibiting the IL33-ST2 Signaling Pathway
por: Lu, Daomin, et al.
Publicado: (2022)

Characteristics of the (Auto)Reactive T Cells in Rheumatoid Arthritis According to the Immune Epitope Database
por: Carlé, Caroline, et al.
Publicado: (2023)

Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review
por: Letarouilly, Jean-Guillaume, et al.
Publicado: (2020)

Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
por: Mariette, Xavier, et al.
Publicado: (2018)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
por: Mercer, Louise K, et al.
Publicado: (2017)

Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
por: Meyer, Magali, et al.
Publicado: (2013)

MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts
por: Alsaleh, Ghada, et al.
Publicado: (2014)

Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis
por: Arias-de la Rosa, Iván, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qj8ssv2ifh83749kejnn75r0sd